155 related articles for article (PubMed ID: 34046973)
1. Serum phosphate and mortality in incident dialysis patients in Australia and New Zealand.
Tiong MK; Ullah S; McDonald SP; Tan SJ; Lioufas NM; Roberts MA; Toussaint ND
Nephrology (Carlton); 2021 Oct; 26(10):814-823. PubMed ID: 34046973
[TBL] [Abstract][Full Text] [Related]
2. Use of phosphate-binding agents is associated with a lower risk of mortality.
Cannata-Andía JB; Fernández-Martín JL; Locatelli F; London G; Gorriz JL; Floege J; Ketteler M; Ferreira A; Covic A; Rutkowski B; Memmos D; Bos WJ; Teplan V; Nagy J; Tielemans C; Verbeelen D; Goldsmith D; Kramar R; Martin PY; Wüthrich RP; Pavlovic D; Benedik M; Sánchez JE; Martínez-Camblor P; Naves-Díaz M; Carrero JJ; Zoccali C
Kidney Int; 2013 Nov; 84(5):998-1008. PubMed ID: 23823605
[TBL] [Abstract][Full Text] [Related]
3. Patient survival on haemodiafiltration and haemodialysis: a cohort study using the Australia and New Zealand Dialysis and Transplant Registry.
See EJ; Hedley J; Agar JWM; Hawley CM; Johnson DW; Kelly PJ; Lee VW; Mac K; Polkinghorne KR; Rabindranath KS; Sud K; Webster AC
Nephrol Dial Transplant; 2019 Feb; 34(2):326-338. PubMed ID: 30124954
[TBL] [Abstract][Full Text] [Related]
4. Multicenter Registry Analysis of Center Characteristics Associated with Technique Failure in Patients on Incident Peritoneal Dialysis.
Htay H; Cho Y; Pascoe EM; Darssan D; Nadeau-Fredette AC; Hawley C; Clayton PA; Borlace M; Badve SV; Sud K; Boudville N; McDonald SP; Johnson DW
Clin J Am Soc Nephrol; 2017 Jul; 12(7):1090-1099. PubMed ID: 28637862
[TBL] [Abstract][Full Text] [Related]
5. Sevelamer Versus Calcium-Based Binders for Treatment of Hyperphosphatemia in CKD: A Meta-Analysis of Randomized Controlled Trials.
Patel L; Bernard LM; Elder GJ
Clin J Am Soc Nephrol; 2016 Feb; 11(2):232-44. PubMed ID: 26668024
[TBL] [Abstract][Full Text] [Related]
6. Serum phosphate and social deprivation independently predict all-cause mortality in chronic kidney disease.
Solbu MD; Thomson PC; Macpherson S; Findlay MD; Stevens KK; Patel RK; Padmanabhan S; Jardine AG; Mark PB
BMC Nephrol; 2015 Dec; 16():194. PubMed ID: 26627078
[TBL] [Abstract][Full Text] [Related]
7. Center Effects and Peritoneal Dialysis Peritonitis Outcomes: Analysis of a National Registry.
Htay H; Cho Y; Pascoe EM; Darssan D; Nadeau-Fredette AC; Hawley C; Clayton PA; Borlace M; Badve SV; Sud K; Boudville N; McDonald SP; Johnson DW
Am J Kidney Dis; 2018 Jun; 71(6):814-821. PubMed ID: 29289475
[TBL] [Abstract][Full Text] [Related]
8. An Incident Cohort Study Comparing Survival on Home Hemodialysis and Peritoneal Dialysis (Australia and New Zealand Dialysis and Transplantation Registry).
Nadeau-Fredette AC; Hawley CM; Pascoe EM; Chan CT; Clayton PA; Polkinghorne KR; Boudville N; Leblanc M; Johnson DW
Clin J Am Soc Nephrol; 2015 Aug; 10(8):1397-407. PubMed ID: 26068181
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of SBR759, a novel calcium-free, iron (III)-based phosphate binder, versus placebo in chronic kidney disease stage V Japanese patients on maintenance renal replacement therapy.
Fukagawa M; Kasuga H; Joseph D; Sawata H; Junge G; Moore A; Akiba T
Clin Exp Nephrol; 2014 Feb; 18(1):135-43. PubMed ID: 23670305
[TBL] [Abstract][Full Text] [Related]
10. Predictors and outcomes of patients switching from maintenance haemodialysis to peritoneal dialysis in Australia and New Zealand: Strengthening the argument for 'peritoneal dialysis first' policy.
Nguyen ANL; Prasad Kafle M; Sud K; Lee VW
Nephrology (Carlton); 2019 Sep; 24(9):958-966. PubMed ID: 30328210
[TBL] [Abstract][Full Text] [Related]
11. Design and baseline characteristics of the LANDMARK study.
Ogata H; Fukagawa M; Hirakata H; Kaneda H; Kagimura T; Akizawa T;
Clin Exp Nephrol; 2017 Jun; 21(3):531-537. PubMed ID: 27405619
[TBL] [Abstract][Full Text] [Related]
12. Low socio-economic status adversely effects dialysis survival in Australia.
Krishnasamy R; Gray NA
Nephrology (Carlton); 2018 May; 23(5):453-460. PubMed ID: 28383177
[TBL] [Abstract][Full Text] [Related]
13. Low serum phosphate as an independent predictor of increased infection-related mortality in dialysis patients: A prospective multicenter cohort study.
Lee JE; Lim JH; Jang HM; Kim YS; Kang SW; Yang CW; Kim NH; Kwon E; Kim HJ; Park JM; Jung HY; Choi JY; Park SH; Kim CD; Cho JH; Kim YL;
PLoS One; 2017; 12(10):e0185853. PubMed ID: 28973026
[TBL] [Abstract][Full Text] [Related]
14. Association of changes in bone mineral parameters with mortality in haemodialysis patients: insights from the ARO cohort.
Lamina C; Kronenberg F; Stenvinkel P; Froissart M; Forer L; Schönherr S; Wheeler DC; Eckardt KU; Floege J
Nephrol Dial Transplant; 2020 Mar; 35(3):478-487. PubMed ID: 31006013
[TBL] [Abstract][Full Text] [Related]
15. Haemodialysis withdrawal in Australia and New Zealand: a binational registry study.
Chan S; Marshall MR; Ellis RJ; Ranganathan D; Hawley CM; Johnson DW; Wolley MJ
Nephrol Dial Transplant; 2020 Apr; 35(4):669-676. PubMed ID: 31397483
[TBL] [Abstract][Full Text] [Related]
16. Frequencies of hepatitis B and C infections among haemodialysis and peritoneal dialysis patients in Asia-Pacific countries: analysis of registry data.
Johnson DW; Dent H; Yao Q; Tranaeus A; Huang CC; Han DS; Jha V; Wang T; Kawaguchi Y; Qian J
Nephrol Dial Transplant; 2009 May; 24(5):1598-603. PubMed ID: 19096083
[TBL] [Abstract][Full Text] [Related]
17. Association between causes of peritoneal dialysis technique failure and all-cause mortality.
Chen JHC; Johnson DW; Hawley C; Boudville N; Lim WH
Sci Rep; 2018 Mar; 8(1):3980. PubMed ID: 29507305
[TBL] [Abstract][Full Text] [Related]
18. An observational outcomes study from 1966-2008, examining pregnancy and neonatal outcomes from dialysed women using data from the ANZDATA Registry.
Shahir AK; Briggs N; Katsoulis J; Levidiotis V
Nephrology (Carlton); 2013 Apr; 18(4):276-84. PubMed ID: 23441694
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of sucroferric oxyhydroxide compared with sevelamer hydrochloride in Japanese haemodialysis patients with hyperphosphataemia: A randomized, open-label, multicentre, 12-week phase III study.
Koiwa F; Yokoyama K; Fukagawa M; Terao A; Akizawa T
Nephrology (Carlton); 2017 Apr; 22(4):293-300. PubMed ID: 27496336
[TBL] [Abstract][Full Text] [Related]
20. Oral phosphate binders in CKD - is calcium the (only) answer?
Goldsmith D; Covic A
Clin Nephrol; 2014 Jun; 81(6):389-95. PubMed ID: 25017668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
